interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Ferric Oxyhydroxide

Generic competition · all medicines · read 12 November 2026

Is there a generic of Ferric Oxyhydroxide, and who makes it?

Ferric Oxyhydroxide appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Ferric Oxyhydroxide1 dosage-form group in the Orange Book
0generic makers listed
  1. Ferric Oxyhydroxide appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Tablet, Chewable, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Velphoro. No generic is listed as marketed.

20102015202020252030203501brand 2013data datePatent 10695367 listed to expire 13 November 2028Patent 11013762 listed to expire 13 November 2028Patent 10933090 listed to expire 13 November 2028Patent 10925897 listed to expire 13 November 2028Patent 10682376 listed to expire 13 November 2028Patent 10925896 listed to expire 13 November 2028Patent 11013761 listed to expire 13 November 2028Patent 11013762*PED listed to expire 13 May 2029Patent 10925896*PED listed to expire 13 May 2029Patent 10925897*PED listed to expire 13 May 2029Patent 10933090*PED listed to expire 13 May 2029Patent 10682376*PED listed to expire 13 May 2029Patent 11013761*PED listed to expire 13 May 2029Patent 10695367*PED listed to expire 13 May 2029Patent 9561251 listed to expire 23 January 2030Patent 9561251*PED listed to expire 23 July 2030Patent 10624855 listed to expire 26 November 2034Patent 11234938 listed to expire 26 November 2034Patent 11446252 listed to expire 26 November 2034Patent 11446252*PED listed to expire 26 May 2035Patent 10624855*PED listed to expire 26 May 2035Patent 11234938*PED listed to expire 26 May 2035Exclusivity NPP to 1 July 2027Exclusivity PED to 1 January 2028
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 1 July 2027Exclusivity NPP Velphoro
  • 1 January 2028Exclusivity PED Velphoro
  • 13 November 2028Patent 10695367 drug product
  • 13 November 2028Patent 11013762 drug product
  • 13 November 2028Patent 10933090 drug product
  • 13 November 2028Patent 10925897 drug product
  • 13 November 2028Patent 10682376 drug product
  • 13 November 2028Patent 10925896 drug product
  • 13 November 2028Patent 11013761 drug product
  • 13 May 2029Patent 11013762*PED

14 more patents are listed.

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.